BiomeMega Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
BiomeMega General Information
Description
Developer of probiotic omega oils designed for the nutraceutical, food, and pharmaceutical industries. The company utilizes precision fermentation and genetic constructs to produce omega fatty acids from probiotic species, bacteria, and filamentous fungi, enabling the nutraceutical and pharmaceutical industries to access sustainable microbiome-derived ingredients for disease prevention and health enhancement.
Contact Information
Website
www.biomemega.comCorporate Office
- 3 Biopolis Drive, Synapse Building (NSG Biolabs)
- Suite 06-11
- Nucleos, 138623
- Singapore
Corporate Office
- 3 Biopolis Drive, Synapse Building (NSG Biolabs)
- Suite 06-11
- Nucleos, 138623
- Singapore
BiomeMega Timeline
BiomeMega Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 15-Mar-2025 | Completed | Startup | |||
| 4. Accelerator/Incubator | 30-Aug-2024 | Completed | Startup | |||
| 3. Angel (individual) | 26-Aug-2024 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Apr-2024 | Completed | Startup | |||
| 1. Accelerator/Incubator | 03-Mar-2023 | Completed | Startup |
BiomeMega Patents
BiomeMega Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026903799-A0 | A genomically divergent lactococcus lactis strain with enhanced lipid metabolism and industrial applications | Pending | 23-Apr-2026 | ||
| AU-2022489394-A1 | Compositions containing probiotic supernatants | Pending | 14-Dec-2022 | ||
| EP-4633392-A1 | Compositions containing probiotic supernatants | Inactive | 14-Dec-2022 | ||
| WO-2024124272-A1 | Compositions containing probiotic supernatants | Inactive | 14-Dec-2022 | ||
| AU-2019258585-A1 | A microbial sanitiser with broad applications | Inactive | 23-Apr-2018 | A23B7/155 |
BiomeMega Signals
BiomeMega Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ajinomoto Group Accelerator | Accelerator/Incubator | |||
| KX Knowledge Xchange | Accelerator/Incubator | |||
| Big Idea Ventures | Venture Capital | Minority | ||
| CSIRO ON Accelerate | Accelerator/Incubator | |||
| INCUBATE | Accelerator/Incubator |
BiomeMega FAQs
-
When was BiomeMega founded?
BiomeMega was founded in 2022.
-
Where is BiomeMega headquartered?
BiomeMega is headquartered in Nucleos, Singapore.
-
What is the size of BiomeMega?
BiomeMega has 5 total employees.
-
What industry is BiomeMega in?
BiomeMega’s primary industry is Biotechnology.
-
Is BiomeMega a private or public company?
BiomeMega is a Private company.
-
What is BiomeMega’s current revenue?
The current revenue for BiomeMega is .
-
How much funding has BiomeMega raised over time?
BiomeMega has raised $299K.
-
Who are BiomeMega’s investors?
Ajinomoto Group Accelerator, KX Knowledge Xchange, Big Idea Ventures, CSIRO ON Accelerate, and INCUBATE have invested in BiomeMega.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process